Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Adriano Care SOCIMI S.A. is a real estate investment trust (REIT) focused on the acquisition and management of properties specializing in healthcare facilities within Spain. The primary function of Adriano Care is to invest in and manage real estate assets that provide essential healthcare services, such as nursing homes and senior living facilities. This specific focus allows Adriano Care to capitalize on the growing demand for healthcare facilities, driven by an aging population and rising healthcare needs. The company strategically develops its portfolio by targeting properties that offer stable rental income and potential for value appreciation. By operating under the SOCIMI framework, Adriano Care benefits from tax advantages, which enhances its ability to generate consistent cash flows and high dividend yields for investors. In the broader financial market, Adriano Care plays a significant role in the healthcare real estate sector, offering investors exposure to the demographic shifts and changing healthcare dynamics within the region. Through its focused investment strategy, Adriano Care SOCIMI S.A. contributes to the sustainable growth of infrastructure critical to delivering quality healthcare services, thus sustaining its market relevance and operational significance.
€9.95
+€0.00 (+0.00%)
EOD Jun 23, 2026 · Twelve Data
49.67% operating margin is above average. ROIC at 3.45%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue grew 8.3%, steady but not accelerating.
Net debt of €99M represents 15.5x FCF, leverage limits flexibility.
11.2x earnings, 18.6x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€17M
▲ +8.3% YoY
Net Income (TTM)
€11M
▲ +786.0% YoY
Op. Margin
49.67%
▲ +4.9pp YoY
ROIC
3.45%
▲ +1.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€6M
▲ +16.9% YoY
Op. Cash Flow (TTM)
€17M
▲ +92.5% YoY
Net Debt
€99M
Cash & Equiv.
€8M
3Y CAGR: +9.3%
Continue Research